KIT (タンパク質)
関連文献

“Stem cell factor receptor/c-Kit: from basic science to clinical implications”. Physiological Reviews 92 (4):  1619–1649. (October 2012). doi:10.1152/physrev.00046.2011. PMID 23073628.
“The stem cell factor receptor/c-Kit as a drug target in cancer”. Current Cancer Drug Targets 6 (1):  65–75. (February 2006). doi:10.2174/156800906775471725. PMID 16475976.
“Signal transduction via the stem cell factor receptor/c-Kit”. Cellular and Molecular Life Sciences 61 (19–20):  2535–2548. (October 2004). doi:10.1007/s00018-004-4189-6. PMID 15526160.
“Early signaling pathways activated by c-Kit in hematopoietic cells”. The International Journal of Biochemistry & Cell Biology 31 (10):  1053–1074. (October 1999). doi:10.1016/S1357-2725(99)00078-3. PMID 10582339. https://zenodo.org/record/1260224.
“CD117”. Journal of Biological Regulators and Homeostatic Agents 15 (1):  90–94. (2001). PMID 11388751.
“Cytogenetic and molecular genetic abnormalities in systemic mastocytosis”. Acta Haematologica 107 (2):  123–128. (2002). doi:10.1159/000046642. PMID 11919394.
“Signal transduction-associated and cell activation-linked antigens expressed in human mast cells”. International Journal of Hematology 75 (4):  357–362. (May 2002). doi:10.1007/BF02982124. PMID 12041664.
“Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. gastrointestinal stromal tumors”. Cancer Genetics and Cytogenetics 135 (1):  1–22. (May 2002). doi:10.1016/S0165-4608(02)00546-0. PMID 12072198.
“Kit as a human oncogenic tyrosine kinase”. Cellular and Molecular Life Sciences 61 (23):  2924–2931. (December 2004). doi:10.1007/s00018-004-4273-y. PMID 15583854.
“The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia”. Leukemia & Lymphoma 46 (2):  247–255. (February 2005). doi:10.1080/10428190400007565. PMID 15621809.
“KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation”. Applied Immunohistochemistry & Molecular Morphology 13 (3):  205–220. (September 2005). doi:10.1097/01.pai.0000173054.83414.22. PMID 16082245. https://zenodo.org/record/1234861.
“KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)”. Seminars in Diagnostic Pathology 23 (2):  91–102. (May 2006). doi:10.1053/j.semdp.2006.08.006. PMID 17193822. https://zenodo.org/record/1235992.
“Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders”. Current Cancer Drug Targets 7 (5):  492–503. (August 2007). doi:10.2174/156800907781386614. PMID 17691909.
“Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene”. Oncogene 7 (11):  2207–2217. (November 1992). PMID 1279499.
“Deletion of the KIT and PDGFRA genes in a patient with piebaldism”. American Journal of Medical Genetics 44 (4):  492–495. (November 1992). doi:10.1002/ajmg.1320440422. PMID 1279971.
“Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism”. American Journal of Human Genetics 50 (2):  261–269. (February 1992). PMC 1682440. PMID 1370874. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682440/.
“p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein”. Proceedings of the National Academy of Sciences of the United States of America 89 (5):  1587–1591. (March 1992). Bibcode: 1992PNAS...89.1587D. doi:10.1073/pnas.89.5.1587. PMC 48497. PMID 1371879. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC48497/.
“Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III”. Oncogene 7 (4):  685–691. (April 1992). PMID 1373482.
“A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses”. The Journal of Biological Chemistry 267 (15):  10866–10873. (May 1992). doi:10.1016/S0021-9258(19)50098-9. PMID 1375232.
“Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene”. The Journal of Clinical Investigation 89 (6):  1713–1717. (June 1992). doi:10.1172/JCI115772. PMC 295855. PMID 1376329. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC295855/.
“Cloning and structural analysis of the human c-kit gene”. Oncogene 7 (7):  1259–1266. (July 1992). PMID 1377810.
“Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells”. The Journal of Biological Chemistry 267 (25):  18021–18025. (September 1992). doi:10.1016/S0021-9258(19)37146-7. PMID 1381360.
“Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow”. Blood 78 (1):  30–37. (July 1991). doi:10.1182/blood.V78.1.30.30. PMID 1712644.